Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4

J Virol. 1998 Mar;72(3):2509-15. doi: 10.1128/JVI.72.3.2509-2515.1998.

Abstract

The chemokine receptors CCR5 and CXCR4, in combination with CD4, mediate cellular entry of macrophage-tropic (M-tropic) and T-cell-tropic strains of human immunodeficiency virus type 1 (HIV-1), respectively, while dualtropic viruses can use either receptor. We have constructed a panel of chimeric viruses and envelope glycoproteins in which various domains of the dualtropic HIV-1(DH12) gp160 were introduced into the genetic background of an M-tropic HIV-1 isolate, HIV-1(AD8). These constructs were employed in cell fusion and virus infectivity assays using peripheral blood mononuclear cells, MT4 T cells, primary monocyte-derived macrophages, or HOS-CD4 cell lines, expressing various chemokine receptors, to assess the contributions of different gp120 subdomains in coreceptor usage and cellular tropism. As expected, the dualtropic HIV-1(DH12) gp120 utilized either CCR3, CCR5, or CXCR4, whereas HIV-1(AD8) gp120 was able to use only CCR3 or CCR5. We found that either the V1/V2 or the V3 region of HIV-1(DH12) gp120 individually conferred on HIV-1(AD8) the ability to use CXCR4, while the combination of both the V1/V2 and V3 regions increased the efficiency of CXCR4 use. In addition, while the V4 or the V5 region of HIV-1(DH12) gp120 failed to confer the capacity to utilize CXCR4 on HIV-1(AD8), these regions were required in conjunction with regions V1 to V3 of HIV-1(DH12) gp120 for efficient utilization of CXCR4. Comparison of virus infectivity analyses with various cell types and cell fusion assays revealed assay-dependent discrepancies and indicated that events occurring at the cell surface during infection are complex and cannot always be predicted by any one assay.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Binding Sites
  • CD4 Antigens / metabolism
  • Cell Line
  • Cell Line, Transformed
  • Chemokine CCL4
  • Chemokine CCL5 / metabolism
  • HIV Envelope Protein gp120 / genetics
  • HIV Envelope Protein gp120 / metabolism*
  • HIV Envelope Protein gp160 / genetics
  • HIV Envelope Protein gp160 / metabolism*
  • HIV-1 / genetics
  • HIV-1 / isolation & purification
  • HIV-1 / metabolism*
  • Humans
  • Leukocytes, Mononuclear / cytology
  • Leukocytes, Mononuclear / metabolism
  • Macrophage Inflammatory Proteins / metabolism
  • Macrophages / virology
  • Membrane Fusion
  • Reassortant Viruses / genetics
  • Reassortant Viruses / isolation & purification
  • Reassortant Viruses / metabolism
  • Receptors, CCR3
  • Receptors, CCR5 / metabolism
  • Receptors, CXCR4 / metabolism*
  • Receptors, Chemokine / metabolism
  • T-Lymphocytes / virology

Substances

  • CCR3 protein, human
  • CD4 Antigens
  • Chemokine CCL4
  • Chemokine CCL5
  • HIV Envelope Protein gp120
  • HIV Envelope Protein gp160
  • Macrophage Inflammatory Proteins
  • Receptors, CCR3
  • Receptors, CCR5
  • Receptors, CXCR4
  • Receptors, Chemokine

Associated data

  • GENBANK/AF069139
  • GENBANK/AF069140